|
MechanismZNF207 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shuangyun Biomedical Technology (Suzhou) Co., Ltd.
0 Patents (Medical) associated with Shuangyun Biomedical Technology (Suzhou) Co., Ltd.
100 Deals associated with Shuangyun Biomedical Technology (Suzhou) Co., Ltd.
100 Translational Medicine associated with Shuangyun Biomedical Technology (Suzhou) Co., Ltd.